Total Knee Prosthesis With Continuous Block of Adductor Canal and Outcome

ASST Gaetano Pini-CTO

Status and phase

Withdrawn

Phase 4

Conditions

Total Knee Arthroplasty

Treatments

Procedure: Local anesthetic infusion

Procedure: Adductor canal

Drug: Levobupivacaine 0,5%

Procedure: Spinal Anesthesia

Drug: Ropivacaine 0,75%

Drug: Levobupivacaine 0,125%

Drug: Morphine

Procedure: Intravenous analgesia

Device: stimulong sono, Pajunk, Germany

Drug: Ketorolac 30mg

Procedure: Femoral

Study type

Interventional

Funder types

Other

Identifiers

NCT02082067

IOGPGC05-14

Details and patient eligibility

About

Aim of this study is to evaluate the effects of the adductor canal block on the early and medium term ( 1 month) rehabilitation compared to the continuous femoral block commonly used in the knee prosthesis.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

patients undergoing total knee arthroplasty

Exclusion criteria

diabetes
neurological disorders
coagulation disorders
rheumatoid arthritis
chronic opioids therapy
allergy to local anesthetic

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

0 participants in 3 patient groups, including a placebo group

Adductor canal

Experimental group

Description:

All patients in the arm will receive continuous adductor canal block under ultrasound guidance. 10ml of Ropivacaine 0,75%, BBraun, Germany, will be injected to dilate adductor canal. After catheter insertion 10ml of Ropivacaine 0,75% will be injected.

Treatment:

Procedure: Spinal Anesthesia

Drug: Morphine

Drug: Ketorolac 30mg

Drug: Levobupivacaine 0,5%

Procedure: Local anesthetic infusion

Procedure: Adductor canal

Device: stimulong sono, Pajunk, Germany

Procedure: Intravenous analgesia

Drug: Ropivacaine 0,75%

Drug: Levobupivacaine 0,125%

Femoral

Active Comparator group

Description:

All patients in the arm will receive continuous femoral nerve block under ultrasound guidance. Correct position of catheter will be check with injection of 20ml Ropivacaine 0,75% BBraun, Germany medial to femoral nerve.

Treatment:

Procedure: Spinal Anesthesia

Drug: Morphine

Drug: Ketorolac 30mg

Drug: Levobupivacaine 0,5%

Procedure: Local anesthetic infusion

Device: stimulong sono, Pajunk, Germany

Procedure: Intravenous analgesia

Drug: Ropivacaine 0,75%

Procedure: Femoral

Drug: Levobupivacaine 0,125%

Controls